JP2023542345A5 - - Google Patents
Info
- Publication number
- JP2023542345A5 JP2023542345A5 JP2023518141A JP2023518141A JP2023542345A5 JP 2023542345 A5 JP2023542345 A5 JP 2023542345A5 JP 2023518141 A JP2023518141 A JP 2023518141A JP 2023518141 A JP2023518141 A JP 2023518141A JP 2023542345 A5 JP2023542345 A5 JP 2023542345A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- monothioglycerol
- sodium phosphate
- hydrocortisone sodium
- impurities
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081164P | 2020-09-21 | 2020-09-21 | |
| US63/081,164 | 2020-09-21 | ||
| PCT/US2021/051349 WO2022061303A1 (en) | 2020-09-21 | 2021-09-21 | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542345A JP2023542345A (ja) | 2023-10-06 |
| JP2023542345A5 true JP2023542345A5 (https=) | 2024-10-01 |
Family
ID=80775681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518141A Pending JP2023542345A (ja) | 2020-09-21 | 2021-09-21 | リン酸ヒドロコルチゾンナトリウム及びモノチオグリセロール水性医薬製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20220096496A1 (https=) |
| EP (1) | EP4213827A4 (https=) |
| JP (1) | JP2023542345A (https=) |
| KR (1) | KR20230104131A (https=) |
| CN (1) | CN116367835A (https=) |
| AU (1) | AU2021345429A1 (https=) |
| CA (1) | CA3192530A1 (https=) |
| IL (1) | IL301352A (https=) |
| MX (1) | MX2023003197A (https=) |
| WO (1) | WO2022061303A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023183807A1 (en) * | 2022-03-21 | 2023-09-28 | Antares Pharma, Inc. | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
| JP2025509955A (ja) * | 2022-03-21 | 2025-04-11 | アンタレス・ファーマ・インコーポレーテッド | リン酸ヒドロコルチゾンナトリウム及びモノチオグリセロール水性医薬製剤 |
| US11904046B1 (en) | 2022-11-14 | 2024-02-20 | Eton Pharmaceuticals, Inc. | Hydrocortisone oral liquid formulations |
| WO2024214110A1 (en) * | 2023-04-08 | 2024-10-17 | Cipla Limited | A safe pharmaceutical composition of hydrocortisone |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA911885A (en) * | 1972-10-10 | Gruppo Lepetit S.P.A. | Stable aqueous steroid phosphate solutions | |
| US2970944A (en) | 1958-04-04 | 1961-02-07 | Merck & Co Inc | Parenteral solutions of steroid phosphates stabilized with creatinines |
| IL34366A (en) * | 1969-05-07 | 1973-06-29 | Lepetit Spa | Stable aqueous 21-hydroxy steroid phosphate solutions |
| US5173488A (en) | 1989-08-21 | 1992-12-22 | American Cyanamid Company | Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| AU702871B2 (en) * | 1993-08-23 | 1999-03-11 | Nexell Therapeutics Inc. | (In vitro) growth of neutrophil and megakaryocyte precursors in serum-free media |
| US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
| CN101132820B (zh) | 2005-01-24 | 2010-05-19 | 安塔雷斯制药公司 | 预充式针辅助喷射注入器 |
| JP2009514969A (ja) * | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | 医学的状態を治療するための方法、組成物、およびキット |
| EP2990067B1 (en) | 2008-03-10 | 2019-09-04 | Antares Pharma, Inc. | Injector safety device |
| AU2010226442A1 (en) | 2009-03-20 | 2011-10-13 | Antares Pharma, Inc. | Hazardous agent injection system |
| US10300207B2 (en) | 2013-03-13 | 2019-05-28 | Antares Pharma, Inc. | Multiple dosage injector with rotating screw dosage system |
| UA119324C2 (uk) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні |
| ES2673290T3 (es) * | 2016-01-11 | 2018-06-21 | Lamda Laboratories S.A. | Soluciones farmacéuticas orales que contienen fosfato sódico de hidrocortisona |
| FR3047904B1 (fr) | 2016-02-18 | 2018-03-23 | Crossject | Dispositif d’injection sans aiguille a membrane coulissante |
| FR3057775B1 (fr) | 2016-10-26 | 2018-11-02 | Crossject | Solution pharmaceutique d’hydrocortisone pour dispositif d’injection |
| US11814341B2 (en) * | 2018-05-04 | 2023-11-14 | Ohio State Innovation Foundation | Non-peptidic cell-penetrating motifs |
| US11034710B2 (en) * | 2018-12-04 | 2021-06-15 | Sumitomo Dainippon Pharma Oncology, Inc. | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer |
-
2021
- 2021-09-21 MX MX2023003197A patent/MX2023003197A/es unknown
- 2021-09-21 JP JP2023518141A patent/JP2023542345A/ja active Pending
- 2021-09-21 EP EP21870423.7A patent/EP4213827A4/en active Pending
- 2021-09-21 CN CN202180074582.6A patent/CN116367835A/zh active Pending
- 2021-09-21 IL IL301352A patent/IL301352A/en unknown
- 2021-09-21 CA CA3192530A patent/CA3192530A1/en active Pending
- 2021-09-21 AU AU2021345429A patent/AU2021345429A1/en active Pending
- 2021-09-21 WO PCT/US2021/051349 patent/WO2022061303A1/en not_active Ceased
- 2021-09-21 KR KR1020237012932A patent/KR20230104131A/ko active Pending
- 2021-10-05 US US17/494,340 patent/US20220096496A1/en not_active Abandoned
-
2022
- 2022-11-18 US US18/056,997 patent/US11857555B2/en active Active
-
2023
- 2023-10-27 US US18/496,559 patent/US20240131035A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542345A5 (https=) | ||
| JP7057360B2 (ja) | 抗－ｃｄ３抗体製剤 | |
| US20140356434A1 (en) | Pharmaceutical formulation | |
| JP2022507103A5 (https=) | ||
| Baldwa et al. | Atomised intranasal midazolam spray as premedication in pediatric patients: comparison between two doses of 0.2 and 0.3 mg/kg | |
| RS59258B1 (sr) | Kombinovana kompozicija | |
| WO2022135395A1 (zh) | 稳定的抗体制剂及其制备方法和应用 | |
| JP2020535147A (ja) | シポニモドの投与レジメン | |
| US4448774A (en) | Steroid formulation | |
| JP2025509955A5 (https=) | ||
| CN107849128A (zh) | 瘙痒治疗 | |
| CN105769759B (zh) | 盐酸昂丹司琼注射液组合物和制法 | |
| Shahar et al. | Obstructive hydrocephalus-induced parkinsonism. I: Decreased basal ganglia regional blood flow | |
| JP2016153374A (ja) | 炎症性疾患を治療又は予防するための医薬組成物 | |
| EP0863759A1 (de) | Verwendung einer kombination aus pentoxifyllin mit typ i-interferonen zur behandlung der multiplen sklerose | |
| RU2023109329A (ru) | Водный фармацевтический состав на основе гидрокортизона натрия фосфата и монотиоглицерина | |
| Arieff | Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone | |
| Katchan et al. | An idiopathic thrombocytopenic purpura with polyneuropathy | |
| CN104797254B (zh) | 匹多莫德治疗特应性皮炎的用途 | |
| Voinov | Plasmapheresis in Treatment of Myasthenia Gravis | |
| JP7630625B2 (ja) | 改善された凍結乾燥製剤 | |
| Ruotsi et al. | A long-term double-blind comparative study on proquazone (Biarison®) and ibuprofen in rheumatoid arthritis | |
| CN113425723B (zh) | Pim1小分子抑制剂在制备防治强直性脊柱炎产品中的应用 | |
| Woo et al. | Use of Methotrexate for the treatment of Ocular Inflammation and Uveitis | |
| Alden et al. | Lupus erythematosus: a modification of therapy with gold compounds |